DK101783D0 - Fremgangsmade til fremstilling af et benzensulfonsyreadditionssalt af sultamicillin - Google Patents

Fremgangsmade til fremstilling af et benzensulfonsyreadditionssalt af sultamicillin

Info

Publication number
DK101783D0
DK101783D0 DK1017/83A DK101783A DK101783D0 DK 101783 D0 DK101783 D0 DK 101783D0 DK 1017/83 A DK1017/83 A DK 1017/83A DK 101783 A DK101783 A DK 101783A DK 101783 D0 DK101783 D0 DK 101783D0
Authority
DK
Denmark
Prior art keywords
sultamicillin
preparing
acid addition
addition salt
benzenesulphonic acid
Prior art date
Application number
DK1017/83A
Other languages
English (en)
Other versions
DK101783A (da
DK162168C (da
DK162168B (da
Inventor
Wayne Ernest Barth
Vytautas John Jasys
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK101783D0 publication Critical patent/DK101783D0/da
Publication of DK101783A publication Critical patent/DK101783A/da
Publication of DK162168B publication Critical patent/DK162168B/da
Application granted granted Critical
Publication of DK162168C publication Critical patent/DK162168C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/28—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with modified 2-carboxyl group
    • C07D499/32—Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK101783A 1982-04-23 1983-02-28 Analogifremgangsmaade til fremstilling af et benzensulfonsyreadditionssalt af sultamicillin DK162168C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37115682 1982-04-23
US06/371,156 US4432987A (en) 1982-04-23 1982-04-23 Crystalline benzenesulfonate salts of sultamicillin

Publications (4)

Publication Number Publication Date
DK101783D0 true DK101783D0 (da) 1983-02-28
DK101783A DK101783A (da) 1983-10-24
DK162168B DK162168B (da) 1991-09-23
DK162168C DK162168C (da) 1992-03-02

Family

ID=23462725

Family Applications (1)

Application Number Title Priority Date Filing Date
DK101783A DK162168C (da) 1982-04-23 1983-02-28 Analogifremgangsmaade til fremstilling af et benzensulfonsyreadditionssalt af sultamicillin

Country Status (27)

Country Link
US (1) US4432987A (da)
EP (1) EP0092968B1 (da)
JP (1) JPS58201792A (da)
KR (1) KR860001279B1 (da)
AU (1) AU536854B2 (da)
CA (1) CA1187484A (da)
CS (1) CS235320B2 (da)
DD (1) DD209632A5 (da)
DE (1) DE3362502D1 (da)
DK (1) DK162168C (da)
EG (1) EG16412A (da)
ES (1) ES521728A0 (da)
FI (1) FI76092C (da)
GR (1) GR78582B (da)
HK (1) HK20588A (da)
HU (1) HU187068B (da)
IE (1) IE54628B1 (da)
IL (1) IL68453A (da)
NO (1) NO156202C (da)
NZ (1) NZ203988A (da)
PH (1) PH18035A (da)
PL (1) PL134978B1 (da)
PT (1) PT76587B (da)
SG (1) SG104087G (da)
SU (1) SU1138030A3 (da)
YU (1) YU43170B (da)
ZA (1) ZA832845B (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5336762A (en) * 1985-11-18 1994-08-09 Access Pharmaceuticals, Inc. Polychelating agents for image and spectral enhancement (and spectral shift)
JPH07110815B2 (ja) * 1985-11-18 1995-11-29 ボ−ド・オブ・リ−ジェンツ、ザ・ユニバ−シティ−・オブ・テキサス・システム 画像及びスペクトル向上（およびスペクトルシフト）のためのポリキレ−ト剤
KR910009271B1 (ko) * 1989-06-20 1991-11-08 김영설 1,1-디옥소페닐실라노일 옥시메틸 D-6-[α-(메틸렌아미노)페닐-아세트아미도]-페니실라네이트와 그의 파라-톨루엔술폰산염
KR100314558B1 (ko) * 1994-05-02 2002-02-28 시오노 호히코 피롤리딜티오카르바페넴유도체의결정과,상기결정을함유한동결건조제제및그제조방법
JP3382159B2 (ja) * 1998-08-05 2003-03-04 株式会社東芝 情報記録媒体とその再生方法及び記録方法
ZA200501418B (en) 2002-08-29 2006-10-25 Taisho Pharmaceutical Co Ltd Benzenesulfonate salts of 4-fluoro-2-cyanopyrrolidine derivatives
ATE440101T1 (de) * 2003-03-27 2009-09-15 Basilea Pharmaceutica Ag Cephalosporin in kristalliner form
JP2007509971A (ja) * 2003-10-31 2007-04-19 アルザ・コーポレーシヨン メトホルミンの増加された吸収のための組成物及び投与形態物
FR2877696B1 (fr) 2004-11-09 2009-09-18 Renault Sas Dispositif et procede d'estimation en temps reel de l'angle de debut de combustion d'un moteur a combustion interne
PT2195293E (pt) 2007-08-22 2014-01-21 Astrazeneca Ab Derivados da ciclopropilamida
UY31432A1 (es) 2007-10-26 2009-05-29 Compuestos de diarilhidantoina
PE20120003A1 (es) * 2009-01-30 2012-02-12 Glaxosmithkline Llc Hidrocloruro de n-{(1s)-2-amino-1-[(3-fluorofenil)metil)etil}-5-cloro-4-(4-cloro-1-metil-1h-pirazol-5-il)-2-tiofenocarboxamida cristalino
TW201039825A (en) 2009-02-20 2010-11-16 Astrazeneca Ab Cyclopropyl amide derivatives 983
WO2011006061A1 (en) * 2009-07-10 2011-01-13 Evolva Sa Diyne compositions
RU2012136148A (ru) 2010-02-18 2014-03-27 Астразенека Аб Новая кристаллическая форма производного циклопропилбензамида
AU2011218490B9 (en) * 2010-02-18 2014-12-18 Astrazeneca Ab Solid forms comprising a cyclopropyl amide derivative
WO2014087972A1 (ja) * 2012-12-03 2014-06-12 株式会社カネカ 還元型補酵素ｑ10誘導体およびその製造方法
KR102177643B1 (ko) * 2013-09-05 2020-11-11 미쓰비시 타나베 파마 코퍼레이션 신규한 결정성 아릴알킬아민 화합물 및 그의 제조 방법
KR102331856B1 (ko) * 2014-10-21 2021-11-29 다케다 야쿠힌 고교 가부시키가이샤 결정 형태의 5-클로로-n4-[2-(디메틸포스포릴)페닐]-n2-｛2-메톡시-4-[4-(4-메틸피페라진-1-일)피페리딘-1-일]피리미딘-2,4-디아민
CN104958318A (zh) * 2015-08-04 2015-10-07 青岛蓝盛洋医药生物科技有限责任公司 一种治疗感染性疾病的药物舒巴坦钠组合物
EP3778567A1 (en) * 2016-01-22 2021-02-17 Sandoz Ag Crystalline eravacycline bis-hydrochloride
US10889577B2 (en) 2016-07-07 2021-01-12 Cyclerion Therapeutics, Inc. Solid forms of an sGC stimulator
WO2019089540A1 (en) * 2017-10-30 2019-05-09 Theracaine Llc Hydrophobic arenesulfonate salts
US11186556B1 (en) * 2018-10-16 2021-11-30 Celgene Corporation Salts of a thiazolidinone compound, solid forms, compositions and methods of use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4234579A (en) * 1977-06-07 1980-11-18 Pfizer Inc. Penicillanic acid 1,1-dioxides as β-lactamase inhibitors
KR830001903B1 (ko) * 1979-02-13 1983-09-19 레오 파마슈티칼 프로덕츠 리미티드 페니실란산유도체의 제조방법
IE49881B1 (en) * 1979-02-13 1986-01-08 Leo Pharm Prod Ltd B-lactam intermediates
US4244951A (en) * 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
IE51516B1 (en) * 1980-10-06 1987-01-07 Leo Pharm Prod Ltd 1,1-dioxapenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate napsylate
GB2084572B (en) * 1980-10-06 1984-07-11 Leo Pharm Prod Ltd 1,1-dioxopenicillanoyloxymethyl 6-(d-aphenylacetamido)penicillanate napsylate
IL64009A (en) * 1980-10-31 1984-09-30 Rech Applications Therap Crystalline 1,1-dioxopenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate tosylate hydrates,their production and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
EP0092968B1 (en) 1986-03-12
SU1138030A3 (ru) 1985-01-30
EP0092968A1 (en) 1983-11-02
FI831392A0 (fi) 1983-04-22
US4432987A (en) 1984-02-21
FI831392L (fi) 1983-10-24
DD209632A5 (de) 1984-05-16
ZA832845B (en) 1984-11-28
IE54628B1 (en) 1989-12-20
DK101783A (da) 1983-10-24
PL241553A1 (en) 1983-11-21
NO156202B (no) 1987-05-04
YU43170B (en) 1989-04-30
PH18035A (en) 1985-03-06
JPH0119395B2 (da) 1989-04-11
CA1187484A (en) 1985-05-21
FI76092C (fi) 1988-09-09
YU90483A (en) 1986-04-30
IE830926L (en) 1983-10-23
DK162168C (da) 1992-03-02
NO156202C (no) 1987-08-19
AU1387183A (en) 1983-11-17
SG104087G (en) 1988-07-15
IL68453A (en) 1986-08-31
AU536854B2 (en) 1984-05-24
GR78582B (da) 1984-09-27
PT76587A (en) 1983-05-01
PT76587B (en) 1986-02-27
ES8406075A1 (es) 1984-07-01
DE3362502D1 (en) 1986-04-17
KR840004437A (ko) 1984-10-15
ES521728A0 (es) 1984-07-01
EG16412A (en) 1989-03-30
HU187068B (en) 1985-11-28
NO831430L (no) 1983-10-24
NZ203988A (en) 1986-01-24
FI76092B (fi) 1988-05-31
HK20588A (en) 1988-03-25
PL134978B1 (en) 1985-09-30
IL68453A0 (en) 1983-07-31
DK162168B (da) 1991-09-23
JPS58201792A (ja) 1983-11-24
CS235320B2 (en) 1985-05-15
KR860001279B1 (ko) 1986-09-05

Similar Documents

Publication Publication Date Title
DK101783D0 (da) Fremgangsmade til fremstilling af et benzensulfonsyreadditionssalt af sultamicillin
DK336783A (da) Fremgangsmaade til fremstilling af methylendiphosphonsyrederivater
DK300883D0 (da) Fremgangsmade til fremstilling af thromobolytiske midler
DK174383D0 (da) Fremgangsmade til fremstilling af et phenylalkylaminoethylsalicylamid
DK427286D0 (da) Fremgangsmaade til fremstilling af tetrafluorbenzoesyre
DK359182A (da) Fremgangsmaade til fremstilling af d-maelkesyre
DK159109C (da) Fremgangsmaade til fremstilling af l-ascorbinsyre
DK159122C (da) Fremgangsmaade til fremstilling af 2-keto-l-gulonsyre
DK161106C (da) Fremgangsmaade til fremstilling af 2-keto-l-gulonsyre
DK582883A (da) Fremgangsmaade til fremstilling af modelis
DK24083D0 (da) Fremgangsmade til fremstilling af 0,0'-dithiodibenzoesyrer
DK40883A (da) Fremgangsmaade til fremstilling af benzothienylallylaminer
DK424083D0 (da) Fremgangsmade til fremstilling af anthracyclinglycosider
DK231481A (da) Fremgangsmaade til fremstilling af diacetonektetogulonsyre
DK486985A (da) Fremgangsmaade til fremstilling af tetrahydrofolinsyre
DK501084A (da) Fremgangsmaade til fremstilling af et metaltellurid
DK518883D0 (da) Fremgangsmade til fremstilling af 1-oxa-beta-lactam-forbindelser
DK219483D0 (da) Fremgangsmade til fremstilling af anthracyclinglycosider
DK385983A (da) Fremgangsmaade til fremstilling af 1-oxacephamer
DK161083C (da) Fremgangsmaade til fremstilling af 7-d-mandelamido-3-(1-sulfomethyltetrazol-5-yl)thiomethyl-3-cephem-4-carboxylsyremononatriumsalt
DK212884D0 (da) Fremgangsmaade til fremstilling af isoxazolylimidazolidinoner
DK432683A (da) Fremgangsmaade til fremstilling af 2-hydroxy-2-phenylethylaminer
DK496183D0 (da) Fremgangsmade til fremstilling af nitroalkaner
DK179183D0 (da) Fremgangsmade til fremstilling af hydroxymethylbutensyrer
DK477682A (da) Fremgangsmaade til fremstilling af aminocyklopentanalkensyrer

Legal Events

Date Code Title Description
PUP Patent expired